Australia markets closed

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.50+0.16 (+0.79%)
As of 09:42AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.17B
Enterprise value 903.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.90
Price/book (mrq)1.78
Enterprise value/revenue 3.84
Enterprise value/EBITDA -4.96

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-39.93%
S&P500 52-week change 318.19%
52-week high 340.50
52-week low 311.46
50-day moving average 322.30
200-day moving average 320.11

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 31M
Shares outstanding 557.4M
Implied shares outstanding 657.4M
Float 853.57M
% held by insiders 11.59%
% held by institutions 1108.82%
Shares short (30 Aug 2023) 414.18M
Short ratio (30 Aug 2023) 412.97
Short % of float (30 Aug 2023) 428.27%
Short % of shares outstanding (30 Aug 2023) 424.70%
Shares short (prior month 30 July 2023) 413.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)29 June 2023


Profit margin -88.97%
Operating margin (ttm)-92.09%

Management effectiveness

Return on assets (ttm)-15.14%
Return on equity (ttm)-28.34%

Income statement

Revenue (ttm)235.47M
Revenue per share (ttm)4.15
Quarterly revenue growth (yoy)13.60%
Gross profit (ttm)84.23M
EBITDA -191.07M
Net income avi to common (ttm)-209.49M
Diluted EPS (ttm)-3.59
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)357.14M
Total cash per share (mrq)6.22
Total debt (mrq)93.03M
Total debt/equity (mrq)14.15%
Current ratio (mrq)6.12
Book value per share (mrq)11.46

Cash flow statement

Operating cash flow (ttm)-123.04M
Levered free cash flow (ttm)-124.55M